The Company After the Name
Chapter 15 - The Company After the Name
Whitmore Biotech entered court-supervised restructuring.
The data division was shut down.
Patients whose information had been sold received notices and compensation. Insurers were forced to disclose decisions influenced by unauthorized profiles. Research programs were reviewed independently.
Some collapsed.
Others survived.
Claire refused permanent control even though Graham’s codicil placed her first in line.
She proposed a public-benefit structure with fixed board terms, patient representatives, scientists, workers, and privacy experts.
Several investors objected.
“The Whitmore name creates value,” one said.
Claire looked at the company’s liabilities.
“The Whitmore name created concealment.”
The company became Meridian Biomedical Trust.
No family name appeared above the entrance.
Michael accepted a temporary advisory role with no voting authority. His compensation was public. His decisions required independent review.
He and Claire began marriage counseling.
They did not treat his return to the library as proof that he had saved her.
Rosa saved the cup.
Claire saved her own refusal.
Michael arrived late enough to witness consequences and early enough to choose differently.
That distinction mattered.
The mansion was sold.
Part of the proceeds funded a medical-coercion legal clinic named for Graham and Luis.
Rosa objected to putting Luis’s name beside a Whitmore.
Then she read Graham’s notes and learned he had tried to protect Luis’s report.
She agreed on one condition.
The clinic’s full name became the Graham Whitmore and Luis Alvarez Center for Informed Choice.
Two men.
May you like
Different wealth.
The same truth.
